Skip to main content
Premium Trial:

Request an Annual Quote

Lisa Giles, Michael Kagnoff

GenMark Diagnostics has appointed Lisa Giles and Michael Kagnoff to its board of directors. It also said that Steve Worland has resigned from the board so he can focus on his role as president and CEO of Effector Therapeutics.

Giles is president and CEO of Giles & Associates Consultancy, a privately held management consulting firm. She also currently serves as CEO of Optivara, a software company owned by Giles & Associates. She is a former VP of strategy development for pharmaceuticals firm G.D. Searle. Kagnoff is a partner at law firm DLA Piper.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.